Skandinaviska Enskilda Banken Ab (Publ) Alkermes Plc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $4 Million - $5.14 Million	-140,902 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$27.94 - $44.61 $212,399 - $339,125	-7,602 Reduced 5.12%	140,902 $4.16 Million
Q3 2018 Nov 05, 2018	BUY	$38.6 - $46.12 $5.73 Million - $6.85 Million	148,504 New	148,504 $6.3 Million

363

182M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.77B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.